Evidence map›Paper›PMID 37948845›Full record

ArticlePerfusion2024

Intracranial hemorrhage in a large cohort of patients supported with veno-venous ECMO. A retrospective single-center analysis.

Clemens Wiest, Thomas Müller, Matthias Lubnow, Christoph Fisser, Alois Philipp, Maik Foltan, Roland Schneckenpointner, Maximilian V Malfertheiner

Open access · hybridAbstract read
In one paragraph

Article in Perfusion, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Clemens WiestClinic and Policlinic of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.ORCID 0000-0002-9735-0781
Thomas MüllerClinic and Policlinic of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Matthias LubnowClinic and Policlinic of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Christoph FisserClinic and Policlinic of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Alois PhilippClinic of Cardiothoracic Surgery, University Hospital Regensburg, Regensburg, Germany.
Maik FoltanClinic of Cardiothoracic Surgery, University Hospital Regensburg, Regensburg, Germany.ORCID 0000-0001-9350-3368
Roland SchneckenpointnerClinic and Policlinic of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
Maximilian V MalfertheinerClinic and Policlinic of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.
University Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntracranial bleeding (ICB) is a serious complication during veno-venous extracorporeal membrane oxygenation (V-V ECMO), with potentially fatal consequences. PURPOSE: This study aimed to evaluate the incidence, time of detection of ICB among patients treated with V-V ECMO and potential risk factors for developing ICB during V-V ECMO.

methodsFive hundred fifty six patients were included in this retrospective single center analysis.

resultsMedian time on V-V ECMO was 9 (IQR 6-15) days. Intracranial bleeding during V-V ECMO was detected in 10.9% of all patients (61 patients with ICB). Only 17 patients with ICB presented obvious clinical symptoms. Intracranial bleeding was detected on cerebral imaging in median after 5 days (IQR 1-14) after starting V-V ECMO. Overall survival to hospital discharge was 63.7% (ICB: 29.5%). Risk factors of ICB before starting V-V ECMO in univariable analysis were platelets <100/nl (OR: 3.82), creatinine >1.5mg/dl (OR: 1.98), norepinephrine >2.5mg/h (OR: 2.5), ASAT >80U/L (OR: 1.86), blood-urea >100mg/dl (OR: 1.81) and LDH >550u/L (OR: 2.07). Factors associated with cannulation were rapid decrease in paCO

conclusionThe results emphasize that ICB is a frequent complication during V-V ECMO. Many bleedings were incidental findings, therefore screening for ICB is advisable. The univariate risk factors reflect the underlying disease severity, coagulation disorders and peri-cannulation factors, and may help to identify patients at risk.

Indexed as

Extracorporeal Membrane OxygenationIntracranial HemorrhagesAdultFemaleHumansMaleMiddle AgedRetrospective StudiesRisk Factorsincidenceintracranial bleedingintracranial hemorrhagerisk factorsveno-venous extracorporeal membrane oxygenation

Identifiers

PMID37948845
PMCPMC11490057
OpenAlexW4388563193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.